SEARCH WITHIN CONTENT
VOLUME 15 , ISSUE 5 ( September-October, 2023 ) > List of Articles
Varsha Narayana Bhat, Shamrao Ramji Wakode, Kiran Ambatwar
Keywords : Birth weight, Cesarean, Comorbidities, Eclampsia, Maternal and fetal outcome, Preeclampsia
Citation Information : Bhat VN, Wakode SR, Ambatwar K. To Study the Average Possible Low Dose of Magnesium Sulfate to Control the Convulsions in Eclampsia in a Tertiary Care Hospital. J South Asian Feder Obs Gynae 2023; 15 (5):560-563.
License: CC BY-NC 4.0
Published Online: 31-10-2023
Copyright Statement: Copyright © 2023; The Author(s).
Objective: The aim of this study is to evaluate the efficacy of minimal effective dose of magnesium sulfate (MgSO4) for control of convulsions in eclampsia and also at reducing the MgSO4-related toxicity thus by reducing the dose of MgSO4 and also to analyze the maternal and perinatal outcomes among these patients. Design: The prospective observational study was carried out between January 2019 and January 2022 at Dr. Shankarrao Chavan Govt Medical College and Hospital, Nanded, Maharashtra. Setting: Tertiary care hospital, Nanded, Maharashtra. Materials and methods: Injection of MgSO4 14 gm loading dose was given at the admission in eclampsia cases, and further doses of MgSO4 were given with close monitoring of patients and a reduction in the number of doses of MgSO4 doses was done as per the patient's condition. If the patient gets the next episode of convulsion, immediately 2 gm IV MgSO4 drip was given. Results: In our study, out of 200 patients, 2.5% of them had received only a loading dose of MgSO4, whereas maximum (61.5%) of them had received 20–24 gm of MgSO4. During the observation period of 5–7 days post delivery, none of the patients had any complications like repeat convulsions, loss of consciousness, or intracranial hemorrhage, even after reducing the possible doses of MgSO4. The recurrence rate of convulsions is 7%. Total MgSO4 doses were administered (in grams) with a mean of 24.83 gm among the study population. There was no significant correlation between doses of MgSO4 received, and the number of convulsions reoccurred with p-value > 0.05. Conclusion: It appears that treatment of eclampsia cases should be individualized by considering the level of consciousness, laboratory parameters, induction delivery interval, convulsion to delivery interval, number of convulsions, and hence deciding further maintenance doses to be given or omitted. Due to the low toxicity profile, reduced monitoring, cost-effectiveness, and equally effective in comparison with the Pritchard regimen, the present regimen is recommended.